Home/Filings/4/0001225208-10-009475
4//SEC Filing

Talecris Biotherapeutics Holdings Corp. 4

Accession 0001225208-10-009475

CIK 0001405197operating

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 7:01 PM ET

Size

5.1 KB

Accession

0001225208-10-009475

Insider Transaction Report

Form 4
Period: 2010-03-31
LYNCH THOMAS J
Sr. VP, Corp. Compliance
Transactions
  • Tax Payment

    Common Stock

    2010-03-31$19.92/sh2,751$54,80021,120 total
Footnotes (1)
  • [F1]The number of shares reported includes restricted share units representing the right to receive 2,631 shares of the Issuer's common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.

Documents

1 file

Issuer

Talecris Biotherapeutics Holdings Corp.

CIK 0001405197

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001405197

Filing Metadata

Form type
4
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 7:01 PM ET
Size
5.1 KB